Qube Research & Technologies LTD Biomea Fusion, Inc. Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$8.37 - $19.8 $224,458 - $530,976	26,817 New	26,817 $389,000
Q4 2022 Feb 14, 2023	SELL	$6.3 - $11.6 $25,949 - $47,780	-4,119 Reduced 27.47%	10,877 $91,000
Q3 2022 Nov 14, 2022	BUY	$9.51 - $13.61 $142,611 - $204,095	14,996 New	14,996 $147,000
Q2 2022 Aug 15, 2022	SELL	$3.0 - $12.03 $53,193 - $213,303	-17,731 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$4.39 - $9.03 $59,954 - $123,322	-13,657 Reduced 43.51%	17,731 $79,000
Q4 2021 Feb 01, 2022	BUY	$7.22 - $12.72 $226,621 - $399,255	31,388 New	31,388 $234,000

104

17.8M

1.68M

410K

Ticker BMEA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,290,600
Market Cap $184M
Description
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.